In 69 dogs with divided hypogastric nerves anesthetized with ketamine and chloralose the outflows of the pelvic vesical branch (PV) and pudendal urethral branch (PU) were recorded, and effects of amygdaloid and olfactory tubercle stimulation on them were studied. Stimulation (2–100 Hz, 3 ms, 0.2 mA) was applied to the amygdaloid body and olfactory tubercle. When the bladder contraction was induced by amygdaloid stimulation, the increased PV and decreased PU appeared after latencies of about 115 and 110 ms, respectively. When the bladder relaxation was, oppositely, elicited by stimulation, the decreased PV and enhanced PU occurred after latencies of 110 and 90 ms, respectively. The PV excitation was elicited by medial parts of the intermediate principal nucleus, medial parts of the medial principal nucleus a part of cortical nucleus and of pericortical nucleus. Inhibition of PV was induced by lateral parts of the medial principal nucleus, medial nucleus, central nucleus and a part of the pericortical nucleus. Olfactory tubercle stimulation elicited PV excitation and PU inhibition with latencies of about 100 ms. The vesicopressor response from the tubercle was not abolished by section of the medial preoptic area, medial hypothalamus and periaqueductal gray, but was abolished by added section of the lateral preoptic area, lateral hypothalamus and lateral mesencephalic tegmentum. At the rostral pontine level, the response was abolished by partial section of the lateral part of the pontine reticular formation ipsilateral to the stimulation.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.